Full Text (PDF)
Review Article

Baruch S. Blumberg: A Visionary in Medical Science and Global Health

Prathmesh Balaji Mahajan, Kasumbiwal Ajay H, Dake Mangesh V, Tambe Pranita

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Pediatric Education and Research 13(2):p 348-386, July-Dec 2025. | DOI: 10.21088/per.2321.1644.13225.90

How Cite This Article:

Kasumbiwal Ajay H., Dake Mangesh V., Tambe Pranita, et al. Baruch S. Blumberg: A Visionary in Medical Science and Global Health. Pediatr. Edu. Res. 2025; 13(2): 384-386.

Timeline

Received : December 22, 2025         Accepted : December 28, 2025          Published : December 30, 2025

Abstract

Baruch Samuel Blumberg (1925–2011) was an American physician, geneticist, and Nobel laureate whose groundbreaking work transformed the understanding and prevention of infectious diseases. His discovery of the Australia antigen led to the identification of the hepatitis B virus (HBV), enabling the development of the first effective HBV diagnostic tests and vaccines. Blumberg’s research not only reduced global hepatitis transmission but also paved the way for modern viral immunology and public health strategies. Beyond virology, he made significant contributions to population genetics and served as the first director of NASA’s Astrobiology Institute, promoting interdisciplinary approaches to understanding life in the universe. His legacy lies in combining scientific curiosity with humanitarian impact, saving millions of lives worldwide.


References

No records found.


About this article


Cite this article

Kasumbiwal Ajay H., Dake Mangesh V., Tambe Pranita, et al. Baruch S. Blumberg: A Visionary in Medical Science and Global Health. Pediatr. Edu. Res. 2025; 13(2): 384-386.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
December 22, 2025 December 28, 2025 December 30, 2025

DOI: 10.21088/per.2321.1644.13225.90

Keywords

• Baruch Blumberg• Hepatitis B• Australia antigen• Nobel Prize• Virology• Vaccine development• Population genetics• Astrobiology

Article Level Metrics

Last Updated

Wednesday 24 June 2026, 11:19:41 (IST)


644

Accesses

2
110
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received December 22, 2025
Accepted December 28, 2025
Published December 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share